Streamline healthcare workflows

Digital Asset helps healthcare companies create HIPAA-compliant workflows with Daml, our multi-party application framework. Daml’s built-in safeguards protect data integrity and privacy.

 

AUTOMATION
Automate manual processes and synchronize disparate systems
Healthcare systems are historically siloed, causing data loss and error-prone reconciliation processes. Daml applications improve the availability of medical data across providers and payers through secure smart contracts.
SECURITY
Securely access patient data across the value chain
Daml’s authorization checks, accountability tracking and need-to-know privacy model ensures data is only shared with the appropriate parties. Create a single-source-of-truth with secure and privacy-preserving workflows.
SCALABILITY
Support various healthcare processes at scale
Daml was built to tackle your toughest workflows from claims processing to patient payments and clinical research. Daml supports your unique processes and deploys anywhere with full application portability.

Build solutions that manage the entire lifecycle of healthcare delivery

We work with the world’s largest healthcare facilities, insurance providers, and pharmaceutical companies to solve persistent business issues, adapt to rapidly evolving regulations, and lower operational cost.

Want to learn how Digital Asset can transform your supply chain?

One of our supply chain specialists will be in touch to give you a firsthand look at what Daml can do.

Digital Asset's Daml, the premier multi-party application framework and smart contract language, is used by some of the most critical healthcare infrastructures and solutions providers in the world.
change
Change Healthcare is reengineering the $1.5 trillion healthcare revenue cycle management system with a Payments Blockchain (PoC) that reduces multiple layers of reconciliation and errors to lower processing costs and expedite payments.
brillio
Brillio is using Daml to bridge data and business process islands throughout a complex enterprise pharmaceutical supply chain and clinical trials.